Solriamfetol for ADHD
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is a Phase 3, multi-center, randomized, 6-week, double-blind, placebo-controlled, parallel-group trial to assess the efficacy and safety of solriamfetol in adolescents aged 12 to \<18 years with ADHD.
Are You a Good Fit for This Trial?
This trial is for adolescents aged 12 to under 18 years who have been diagnosed with ADHD. Participants should generally be in good health aside from their ADHD.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Solriamfetol
Trial Overview
The study is testing two different doses of the drug solriamfetol compared to a placebo (inactive pill) over six weeks. Participants are randomly assigned to one of the groups, and neither they nor the researchers know which treatment they're getting.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Placebo Group
Up to 6 weeks
Up to 6 weeks
Up to weeks
Find a Clinic Near You
Who Is Running the Clinical Trial?
Axsome Therapeutics, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.